Purchase Order 75N95022P00737

Award Date 9/26/22
Potential Completion Date 9/25/23
Potential Value $35K
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences (NCATS) awarded a $436,078.00 firm fixed-price purchase order to Accretech America Inc., a foreign-owned, for-profit manufacturer of goods, to provide an "On-Chip Sort Microfluidic Cell Sorter and Accessories" or a brand-name equal. The award, which has no set-aside designation, was issued on June 12, 2019 and requires delivery and installation within 12-16...
This $164,950 firm-fixed-price purchase order was awarded by the Department of Health and Human Services National Institutes of Health National Institute on Aging (NIH/NIA) to Nanocellect Biomedical Inc., a for-profit organization, for a benchtop cell sorter system. The requirement originated from a pre-solicitation notice seeking information on qualified small business sources capable of providing the specified cell sorting equipment, software, and related accessories and services. No set-aside...
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to STEMCELL Technologies Inc., a foreign-owned, for-profit biotechnology company. The $87,530 contract provides for preventive maintenance and service on two RoboSep cell separators used by the NIH's Department of Transfusion Medicine for automated isolation of cells for chimerism testing on bone marrow and stem cell transplant patients. The contract has a base year plus four one-year...
The Department of Health and Human Services National Institutes of Health (NIH) awarded a firm-fixed-price purchase order contract to Nanocellect Biomedical Inc., a for-profit organization, for a microfluidic cell sorter. The total potential value of the contract is $149,680.00, with a completion date of August 31, 2022. The contract does not have a set-aside designation. Nanocellect Biomedical is a biotechnology company that provides automated cell analysis, sorting, and dispensing equipment,...
This is a $23,906 firm fixed price purchase order awarded to Fujifilm Cellular Dynamics, Inc., a foreign-owned, for-profit manufacturer of biologically relevant human cells derived from induced pluripotent stem cells (iPSCs). The award is from the National Center for Advancing Translational Sciences (NCATS), which is part of the National Institutes of Health (NIH) within the Department of Health and Human Services. The contract is for the delivery of various iPSC-derived cell types, such as...
This is a firm-fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to Molecular Devices LLC, a subsidiary of Danaher Corporation. The $208,187.00 contract provides an annual service agreement for Molecular Devices' FLIPR Tetra high-throughput cellular screening systems, which are used in NCATS' research on GPCR, ion channel, and stem cell projects with implications for pain and opioid...
This is a $100,000.00 firm fixed price purchase order awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency, to Nanocellect Biomedical Inc., a small business, for a small sized cell sorter with single cell dispenser. The award was made on August 6, 2018 with an ultimate completion date of August 5, 2019. Nanocellect Biomedical has provided cell sorting systems and related services to various federal agencies, and this contract supports the company's...
The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, has awarded a $138,675.74 firm-fixed-price purchase order to Sony Biotechnology Inc. for a one-year maintenance agreement on a SONY SH800SFP cell sorter. This sole-source acquisition does not have a set-aside designation. As a manufacturer of flow cytometry and imaging instrumentation, Sony Biotechnology has been awarded numerous prime federal contracts...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health, National Center for Advancing Translational Sciences, to Namocell Inc., a for-profit organization, for the supply of a Namocell Hana Single-Cell Dispenser with installation, training, and service agreement. The total potential value of the contract is $115,000.00. The purchase order does not have a set-aside designation. The equipment provided under this contract...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a Firm Fixed Price purchase order contract worth $265,048.50 to Life Technologies Corporation, a for-profit manufacturer of scientific instruments, reagents, and consumables. The contract is for the delivery of assorted cell culture medium, substrate, and supplements manufactured by Life Technologies. This contract supports the Stem Cell Translation Laboratory within the National...

This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), which is part of the National Institutes of Health (NIH), to PHC Corporation of North America, a foreign-owned for-profit organization, for an annual maintenance agreement on an On-Chip Sort microfluidic cell sorter. The contract has a ceiling value of $35,000.00 and covers a base period of 12 months from September 26, 2022 to September 25, 2023, with two 12-month option periods. The cell sorter is used by NCATS' Division of Preclinical Innovation to support research projects focused on understanding pluripotent stem cell biology and enabling stem cell-based drug discovery and disease modeling. This contract was awarded under a competitive solicitation without any set-aside designation.

Generated 8/20/24, 9:09 AM